Abbott
Abbott to acquire Bigfoot Biomedical
September 6, 2023Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes
Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …
FDA approves Abbott’s Assert-IQ insertable cardiac monitor
May 19, 2023Research and Development Abbott, Cardiology, Devices, FDA, heart monitor, medical devices
Abbott has announced that the US Food and Drug Administration (FDA) has granted its clearance for the Assert-IQ insertable cardiac …
FDA approves Abbott’s rapid portable COVID-19 test
August 27, 2020Research and Development Abbott, COVID-19, FDA, test
The FDA has given emergency clearance for Abbott’s portable COVID-19 test that it will sell for just $5. The company’s …
Abbott’s COVID-19 test, used at the White House, fails to identify up to 48% of positive cases, study argues
May 15, 2020Medical Communications, Research and Development Abbott, COVID-19, coronavirus, pharma
Abbott’s 13-minute ID NOW COVID-19 testing kits have come under scrutiny after a study from New York University (NYU) revealed …
FDA approves alternative approach for Abbot HeartMate 3 heart pump
January 8, 2020Research and Development Abbott, FDA, Heart Pump, US Pharma, heart disease
The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump. The …
Abbott CEO to step down after 21 years
November 13, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, appointment
After more than two decades at the head of the company, it has emerged that Miles D White (pictured, right) …
Abbott to boost heart valve therapy portfolio with acquisition of Cephea Valve Technologies
January 17, 2019Manufacturing and Production, Sales and Marketing Abbott, Cephea, acquistion, mitral valve disease, pharma
As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm …
Allergan appoints ex-Abbott exec in “Board refreshment” move
June 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma
Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …
Abbott teams up with Angle for metastatic breast cancer study
February 6, 2018Manufacturing and Production, Research and Development Abbott, Angle, Cancer, breast cancer, pharma
Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …
Pharmafile.com’s top ten stories of 2017
December 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit
After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …
Novartis, Abbott targeted by Indian watchdog over allegations of price collusion
December 14, 2017Sales and Marketing Abbott, Emcure Pharma, Galdus, Novartis, USV, diabetes, pharma, vildagliptin
Novartis, Abbott, Emcure Pharma and USV have become the targets of an investigation by the Competition Commission of India (CCI) …
To succeed in emerging market medicine, anticipation and innovation are essential
December 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical
Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …
Research into clinical trial transparency shows huge variation in standards
July 28, 2017Medical Communications, Sales and Marketing Abbott, GSK, biotech, clinical trials, drugs, pharma, pharmaceutical, transparency
A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to …
AbbVie loses $15 million Depakote birth-defect case
June 12, 2017Sales and Marketing AbbVie, Abbott, Depakote
Court cases for the anti-seizure medicine Depakote continue to rumble on for AbbVie, with the latest case finding AbbVie liable …
26 die after attempting to replace Abbott’s blood pump controller themselves
May 24, 2017Medical Communications, Sales and Marketing Abbott, FDA, Medical device, deaths
At least 26 advanced heart failure patients have died and 19 have been injured by attempting to change the controller …
Latest content
